FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1956002: Buclizine hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4379013 Buclizine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
747815011 Buclizine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
796011000172111 chlorhydrate de bulclizine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buclizine hydrochloride Is a Product containing buclizine (medicinal product) false Inferred relationship Some
Buclizine hydrochloride Is a Sedating antihistamine false Inferred relationship Some
Buclizine hydrochloride Is a Buclizine (substance) false Inferred relationship Some
Buclizine hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine receptor antagonist (disposition) true Inferred relationship Some
Buclizine hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Buclizine (substance) true Inferred relationship Some
Buclizine hydrochloride Is a Benzene derivative hydrocarbon true Inferred relationship Some
Buclizine hydrochloride Is a Histamine receptor antagonist true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Buclizine hydrochloride 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Buclizine hydrochloride Inferred relationship Some
Buclizine hydrochloride 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Buclizine hydrochloride Inferred relationship Some 1
Buclizine hydrochloride 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Buclizine hydrochloride Inferred relationship Some 1
Buclizine hydrochloride 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Buclizine hydrochloride Inferred relationship Some 1
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Buclizine hydrochloride Inferred relationship Some 1
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Buclizine hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start